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121
. The factor is a potent vasodilator and inhibitor of platelet adhesion and aggregation ( Fig. 3) . Nitric oxide has a similar half-life and mode of action to EDRF and the amounts released from endothelial cells appear sufficient to explain the biological activity of the factor in vascular tissues and in platelets'" 1 . L-arginine is the precursor substance from which nitric oxide is cleaved in endothelial cells'
201
. Thus, the endothelium produces an endogenous nitrate which causes relaxation of vascular smooth muscle and inhibition of platelet function. EDRF is released in response to flow (shear stress), platelet-derived products (i.e. adenosine diphosphate, thrombin, serotonin) and hormones and autocoids (i.e. bradykinin, histamine, noradrenalin, substance P and vasopressin)' . Aggregating platelets release enough adenine nucleotides and serotonin to induce endothelium-dependent relaxations in isolated blood vessels'
231
. Adenosine diphosphate is the main mediator of the response to aggregating platelets in human coronary arteries, while the effects of serotonin and thromboxane A 2 are endotheliumindependent (Fig. 3) 
1241
. Several platelet-derived products stimulate the endothelial production of EDRF as well as that of PGI 2 and tissue plasminogen activator 171 . Thus, at sites where platelets are activated, potent vasodilators and inhibitors of platelet function are released which may provide a protective mechanism against vasospasm, ischaemia and thrombus formation.
In addition, the endothelium must release an endothelium-derived hyperpolarizingfactor (EDHF; Fig. I) 
1251
. The sodium-potassium -.ATPase in-hibitor, ouabain, reduces endothelium-dependent relaxations to acetylcholine in the canine femoral artery 261 . Acetylcholine causes endothelium-dependent increases in membrane potential of vascular smooth muscle cells which can be blocked by ouabain 1271 . Exogenous nitric oxide does not hyperpolarize vascular smooth muscle cells nor does haemoglobin prevent the increase in membrane potential in response to acetylcholine, indicating that an endothelium-derived substance other than EDRF must be involved' 28 '. Although the physiological role of this factor is unclear yet, hyperpolarization of vascular smooth muscle cells may contribute to the sustained phase of endotheliumdependent relaxations and it may render the cells less responsive to contractile stimuli.
ENDOTHELIUM-DERIVED CONTRACTING FACTOR(S)
Under certain conditions, the endothelium can mediate vasoconstriction ( Whether the endothelium-derived contracting factor released under hypoxic conditions in the canine coronary artery is endothelin or an as yet unknown substance is uncertain'
311
. In addition, the endothelium and vascular wall possess an independent renin-angiotensin system which may provide high local concentrations of the potent vasoconstrictor angiotensin // 32) . Histamine, thromboxane A 2 and another cyclooxygenase-dependent endotheliumderived contracting factor can also be produced in endothelial cells of certain vascular beds (Fig. I) 
171
. Thus, the endothelium profoundly affects vascular smooth muscle tone and platelet function by the release of endothelium-derived relaxing and contracting factors (Fig. 1) . Under physiological conditions, endothelium-derived relaxing factors most likely dominate. Indeed, in normal human conduit arteries and in mesenteric resistance arteries of the rat, EDRF overrides endothelin' 33 -341 . An alteration of the release of endothelium-derived relaxing and/or contracting factors under pathological conditions, on the other hand, may be important in the pathophysiology of cardiovascular disease.
Cardiovascular risk factors and the endothelium
Risk factors for coronary artery disease such as hyperlipidaemia, atherosclerosis and hypertension impair endothelium-dependent relaxations in experimental animals and in human coronary arteries. In the rabbit aorta, low-density lipoprotein (LDL), but not high-density lipoprotein (HDL), inhibits endothelium-dependent relaxations in response to acetylcholine 1351 . The inhibitory concentration of the lipoprotein corresponds to that found in plasma of patients with severe hyperlipidaemia. In addition, LDL and atherosclerosis inhibit vascular prostacyclin production 136 '. In atherosclerotic arteries, including the human coronary artery, endothelium-dependent relaxations in response to acetylcholine, adenosine diphosphate, bradykinin, substance P and aggregating platelets are reduced ( . A reduced release of EDRF, structural changes of the intima and media, and -at least in the porcine coronary artery -the release of an endothelium-derived contracting factor are responsible for these changes in atherosclerotic arteries' 3 ' 41 ' . In experimental hypertension, endothelium-dependent relaxations are reduced in most vascular beds ( '. In the carotid artery of hypertensive rats, endothelium-dependent relaxations in response to acetylcholine and adenosine diphosphate are blunted' 42 '. This may be important in the development of stroke, which is the majorcardiovascularcomplicationoftheseanimals. In the canine coronary circulation, acute hypertension selectively and persistently attenuates endothelium-dependent responses to serotonin.' 431 Contractions in response to endothelin areenhanced in renal, but not in mesenteric resistance arteries of hypertensive rats' 33341 . Endothelin almost completely inhibits the effects of EDRF in hypertensive, but not in normotensive arteries.' 33 
'

Ischaemia, myocardial infarction and the endothelium
In vitro, hypoxia and ischaemia inhibit the production and release of endothelium-derived relaxing factor and -at least in the canine coronary Figure 6 Effect of antihypertcnsive therapy on endotheliutn-dependent relaxations in response to thrombin IUml" 1 in the aorta of Dahl salt-sensitive (left) and saltresistant (right) rats on a diet containing either 8% or 01% NaCl. Note the normalization of the response to thrombin in salt-sensitive rats on 8% NaCl (i.e. hypertensive group) during antihypertensive therapy (AHD) (from ref. 78 , by permission of the American Heart Association). Q =8% NaCl. K = 0-l% NaCl; 3=8% NaCl + AHD (2 weeks); 3 = 8% NaCl +AHD(8weeks).
infusion of a perfluorochemical'
491
. Reperfusioninduced endothelial dysfunction appears to persist as does that after mechanical injury (see section on endothelium dysfunction and vascular occlusion) 1501 .
Endothelium-depeudent responses and coronary vasospasm
Coronary artery spasm can contribute to myccardial ischaemia' . All these substances exert endothelium-dependent inhibitory and direct excitatory effects. Thus, a local loss of EDRF and/or the release of an endothelium-deri ved contracting factor may precipitate coronary spasm in response to these substances. Intracoronary acetylcholine produces paradoxical contractions in patients with coronary artery disease ( contractions in response to the amine. In the pig, coronary vasospasm can be provoked by histamine at sites of previous endothelial denudation in conjunction with an atherogenic diet'
581
. A local increase in adventitial mast cells, which are a major source of histamine, has been documented in a patient with coronary spasm'
591
. Coronary arteries of patients with coronary artery disease contain increased amounts of histamine and exert enhanced contractions in response to the amine 1601 . Thus, at sites of previous endothelial injury and dysfunction, the direct vasoconstrictor effects of the amine may predominate and precipitate vasospasm. However, histamine is effective in provoking vasospasm only in some, but not all patients with variant angina 1541 . Consistent with platelet activation, coronary sinus thromboxane B 2 levels are elevated during attacks of variant angina' 61 '. Thus, platelet-derived substances such as serotonin, adenosine diphosphate and thrombin are abundantly present and may contribute to the contraction of the diseased arterial segment. In vivo endothelial denudation of the coronary artery leads to spontaneous contraction and enhanced vasoconstrictor responses to serotonirf 62 -63 \ Porcine coronary arteries with regenerated endothelium after balloon injury exhibit a selective and persistent defect of endotheliumdependent relaxations in response to serotonin and aggregating platelets (Fig. 7) 1631 . In addition, contractions induced by serotonin are enhanced in pig coronary artery rings with regenerated endothelium, suggesting the release of an endothelium-derived contracting factor. In man, the defect would have to involve a platelet-derived mediator other than serotonin, since the monoamine does not induce the release of EDRF in human arteries' 24 ' 571 .
Endothelium dysfunction and vascular occlusion
In normal blood vessels, the release of EDRF, prostacyclin and tissue plasminogen activator from endothelial cells may help prevent vasospasm and thrombus formation. In atherosclerotic arteries, platelets become activated indicating an increased platelet-vessel wall interaction. Coronary sinus blood from patients with coronary artery disease exhibits vasoconstrictor activity in isolated arteries and this effect is related to the severity of the disease (641 ._Endothelial dysfunction may be a crucial factor allowing platelet deposition and activation, release of platelet-derived substances and, in turn, decrease in local blood flow.
In man, increased platelet-vessel wall interactions are particularly important in the pathophysiology of unstable angina. Coronary angioscopy in patients with this syndrome reveals complex plaques with intimal haemorrhage and thrombi, while these findings are lacking in patients with stable angina'
651
. At the site of intravascular haemorrhage, free haemoglobin may inhibit EDRF. In the dog, thromboxane A 2 receptor antagonists inhibit cyclic variations in flow as well as platelet deposition in stenosed coronary arteries' 661 . This indicates that there is a continuous build-up and flush-away of platelet clots interfering with local blood flow. Endothelial injury of a large conduit artery provokes collateral arterial vasoconstriction mediated by serotonin and thromboxane A 2 released from platelets adhering and aggregating at the site of endothelial denudation'
671
. Substances interfering with either the production or the vascular effects of platelet-derived products (i.e. cyclooxygenase inhibitors, calcium-channel antagonists), on the other hand, improve symptoms or the incidence of subsequent myocardial infarction in patients with unstable angina' 68 "
701
. This indicates that altered intimal surface characteristics, most likely a decreased release of EDRF and PGI 2 at sites of atherosclerosis and intimal bleeding, are associated with platelet activation and deposition and the release of platelet-derived substances. All these events favour vasoconstriction of epicardial coronary arteries as well as of collaterals, and thrombus formation.
Arterial and venous coronary bypass vessels may provide a model to study possible mechanisms involved in vascular occlusion in vitro in human tissue. As a graft, the internal mammary artery has remarkedly higher patency rate than the saphenous vein. Since this difference persists, if grafts supplying the same vascular bed (i.e. left anterior descending coronary artery) are compared, this indicates that different biological properties of arterial and venous bypass vessels must be involved 17 ' 1 . In mammary arteries, acetylcholine induces complete endothelium-dependent relaxations and induces a marked rise in cyclic GMP levels in vascular smooth muscle cells (Fig. 2)' 10 -
721
. The response evoked by the muscarinic agonist is unaffected by indomethacin, but inhibited by methylene blue and haemoglobin, identifying EDRF as the mediator. In contrast to the mammary artery, saphenous veins exhibit much weaker endothelium-dependent relaxations in response to acetylcholine (Fig. 8 
Therapeutic implications
Functional changes of the endothelium in atherosclerosis and hypertension are at least partly reversible' 77 " 801 . In the aorta of cholesterol-fed rabbits, treatment with the phosphodiesterase inhibitor, dipyramidole, augments or normalizes the impaired endothelium-dependent relaxations to acetylcholine and adenosine triphosphate' 791 . Similarly, non-hypotensive dosages of calcium-channel antagonists -which suppress the development of atherosclerosis -partially restore endothelium-dependent relaxations in response to acetylcholine 1801 . Eighteen months after cessation of an atherogenic diet, endothelium-dependent relaxations normalize in the iliac artery of atherosclerotic primates' 771 . In the aorta of rats with salt-induced hypertension, antihypertensi ve therapy normalizes blood pressure and restores the blunted endothelium-dependent relaxations to acetylcholine, adenosine diphosphate and thrombin (Fig. 6f s \
On the other hand, dietary components which are known to protect from coronary artery disease and stroke, improve endothelial function. Populations with a high dietary fish consumption exhibit a low death rate from coronary artery disease 1811 . In the pig, the development of coronary atherosclerosis can be delayed by dietary cod-oil supplementation 1821 . Dietary supplementation with fish-oil or its active component, eicosapentaenoic acid, markedly enhances endothelium-dependent relaxations in response to aggregating platelets and plateletderived substances, such as adenosine diphosphate, serotonin and thrombin, in isolated porcine coronary arteries and augments the release of EDRF from cultured endothelial cells' 
